These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7489996)

  • 21. Killing effects of ganciclovir on human pulmonary adenocarcinoma cell A549 transduced with HSV1-TK gene in vitro and in vivo.
    He XL; Guo XJ; Qian GS; He XH; Huang GJ; Chen WZ; Li SP
    Acta Pharmacol Sin; 2001 Oct; 22(10):901-6. PubMed ID: 11749772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
    Hasegawa H; Shimada M; Yonemitsu Y; Utsunomiya T; Gion T; Kaneda Y; Sugimachi K
    Cancer Gene Ther; 2001 Apr; 8(4):252-8. PubMed ID: 11393277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
    Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir.
    Rivas C; Miller AR; Collado M; Lam EW; Apperley JF; Melo JV
    Mol Ther; 2001 May; 3(5 Pt 1):642-52. PubMed ID: 11356068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antitumor gene therapy using suicide genes].
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Medicina (B Aires); 1998; 58(2):185-8. PubMed ID: 9706253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
    Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.
    Hamel W; Magnelli L; Chiarugi VP; Israel MA
    Cancer Res; 1996 Jun; 56(12):2697-702. PubMed ID: 8665496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H; Lu R; Ding R; Kan YW
    Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the Good Samaritan effect.
    Wygoda MR; Wilson MR; Davis MA; Trosko JE; Rehemtulla A; Lawrence TS
    Cancer Res; 1997 May; 57(9):1699-703. PubMed ID: 9135011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J; Ma L; Wei L
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
    Harada Y; Iwai M; Tanaka S; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Jan; 7(1):27-36. PubMed ID: 10678353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J; Chen Y; Li H; Lu Y; Yan Y; Tan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
    Princen F; Robe P; Lechanteur C; Mesnil M; Rigo JM; Gielen J; Merville MP; Bours V
    Clin Cancer Res; 1999 Nov; 5(11):3639-44. PubMed ID: 10589781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An experimental application of gene therapy for human retinoblastoma.
    Hayashi N; Ido E; Ohtsuki Y; Ueno H
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):265-72. PubMed ID: 9950583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
    Wills KN; Huang WM; Harris MP; Machemer T; Maneval DC; Gregory RJ
    Cancer Gene Ther; 1995 Sep; 2(3):191-7. PubMed ID: 8528962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
    J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.